Short Summary
Takeda Pharmaceutical Co. Ltd filed an appeal under Section 117A of the Patent Act, 1970, challenging the Deputy Controller of Patents & Designs' order dated April 12, 2023, which rejected its application for patent registration.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Takeda Pharmaceutical Co. Ltd vs Controller Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Anil RathivsSanjog Steels Pvt. Ltd.
The Delhi High Court issued several interim orders in the dispute concerning the 'RATHI' trademark. The court restrained Defendant No. 4 from granting new licenses related to the mark until further hearing, providing immediate relief to the plaintiff. Furthermore, the court mandated that certain defendants maintain and file detailed accounts of sales made under the 'RATHI' trademark during a specified period, while also allowing for the impleadment of proposed parties.
Ctr Manufacturing Industries Ltd.vsSerji Transformer Explosion Prevention Technologies Private Limited
The petitioner (CTR) filed four Notices of Motion alleging that the respondent (Sergi) was repeatedly and contumaciously breaching prior restraint orders issued in a patent infringement suit. The judgment addressed these 'contempt Motions', which were tied to an ongoing appeal regarding CTR's patent for explosion and fire detection technology.
Galatea Ltd.vsM. Kantilal Exports
This case involved multiple suits concerning patent and copyright infringement, where petitioners sought the appointment of a local commissioner to inspect infringing activities. The High Court found that the initial commission report was flawed because it did not follow mandatory provisions of the Civil Procedure Code, specifically regarding issuing notice to respondents before inspection. Consequently, the court discarded the existing reports and directed the trial court to issue a fresh commission.
Sugen, Inc.vsMr. K Vijaya Prakash
Sugen, Inc. filed applications alleging that Mr. K Vijaya Prakash and associated defendants willfully violated an injunction order passed by the Delhi High Court in 2016. The original suit concerned the infringement of three patents covering the drug Crizotinib (marketed as Xalkori®). Plaintiffs presented evidence, including photographs and investigator reports, suggesting the manufacturing and sale of the generic product 'CRIZO SPL™' after the injunction was issued. The court found that Defendant No. 1 had control over the infringing entities, leading to a finding of wilful contempt against him.
Natco Pharma LimitedvsBristol Myers Squibb Company And Anr
The court consolidated a rectification petition and a suit related to the same patent. An additional issue was framed regarding whether Indian Patent IN 247381 is liable for revocation under specific sections of the Patents Act, 1970.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.